Lipids Online - Educational Resources in atherosclerosis,coronary heart disease, hdl cholesterol, ldl cholesterol

Lipids Online - Educational Resources in atherosclerosis,coronary heart disease, hdl cholesterol, ldl cholesterol

• Lipids Online Resources
  • Increased Cardiovascular Disease Risk in Type 2 Diabetes: Pathophysiology
    Slide Library - Posted October 2009
  • High-Density Lipoprotein and the Epidemiology of Coronary Heart Disease
    Slide Library - Posted October 2009
  • Relationship of Glycemia to Cardiovascular Disease: Role of Antidiabetic Agents in Cardiovascular Risk Reduction
    Slide Library - Posted March 2009
  • Management of Low High-Density Lipoprotein in Cholesterol and High Triglycerides in the Patient With Increased Cardiometabolic Risk
    Reports on Cardiometabolic Disorders - Posted February 2009
  • Inhibition of the Endocannabinoid System as an Emerging Therapy to Target Complex Cardiometabolic Risk Factors
    Reports on Cardiometabolic Disorders - Posted December 2008
  • An Evolving Approach to the Treatment of Type 2 Diabetes
    Reports on Cardiometabolic Disorders - Posted July 2008
  • Obesity, Type 2 Diabetes, and Cardiovascular Disease
    Reports on Cardiometabolic Disorders - Posted June 2008
  • A Mandate for Early Intensive Treatment of Abdominal Obesity and Cardiometabolic Risk: Why Weight?
    Virtual Meetings - Posted December 2007
  • Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication
    Clinical Cases - Posted December 2007
  • Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication
    Clinical Cases - Posted December 2007
  • A Mexican American Woman with Multiple Metabolic Risk Factors
    Clinical Cases - Posted November 2007
  • Prevention of Diabetes
    Slide Library - Posted August 2007
  • Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness (CIMT) in Low Risk Individuals with Subclinical Atherosclerosis: The METEOR Trial
    Commentaries on Research - Posted August 2007
  • Update on TZDs, Diabetes, and Cardiovascular Disease: Pioglitazone
    Commentaries on Research - Posted August 2007
  • Update on TZDs, Diabetes, and Cardiovascular Disease: Rosiglitazone
    Commentaries on Research - Posted August 2007
  • Therapeutic Options for Modifying Cardiovascular and Metabolic Risk Factors
    Slide Library - Posted May 2007
  • Carotid Intima-Media Thickness in Atherosclerosis Using Pioglitazone (CHICAGO trial)
    Commentaries on Research - Posted March 2007
  • Reduction of Low-Density Lipoprotein Cholesterol in Patients with Coronary Heart Disease and Metabolic Syndrome: Analysis of the Treating to New Targets (TNT) Study
    Commentaries on Research - Posted January 2007
  • The Biology of the Endocannabinoid System and Its Relation to Obesity
    Slide Library - Posted December 2006
  • The "Weight" of the Evidence Is In: Overweight Is "Widespread" and Deadly
    Commentaries on Research - Posted December 2006
  • Prevention of Diabetes: Why, How, and When
    Virtual Meetings - Posted November 2006
  • Effects of Physical Activity and Exercise on Reducing Risk for Cardiovascular Disease and Diabetes, with a Focus on the Obese Patient
    Slide Library - Posted November 2006
  • Strategies for Lifestyle Modification in the Prevention of Diabetes and Cardiovascular Disease
    Slide Library - Posted September 2006
  • Modifying Cardiovascular and Metabolic Risk Factors: The Role of the Endocannabinoid System (An Educational Program for Primary Care Providers)
    Virtual Meetings - Posted August 2006
  • The Metabolic Syndrome: Introduction and Definitions
    Slide Library - Posted July 2006
  • The Endocannabinoid System: Novel Considerations in the Management of Cardiac and Metabolic Risk (An Educational Program for Cardiologists)
    Virtual Meetings - Posted July 2006
  • Early statin treatment following acute myocardial infarction and 1-year survival.
    Commentaries on Research - Posted March 2004
  • C-Reactive Protein, Metabolic Syndrome, and Cardiovascular Events in Women
    Commentaries on Research - Posted May 2003
  • Epidemiology of Insulin Resistance, Diabetes Mellitus, and CHD
    Slide Library - Posted November 2000
• Bibliography of Guidelines and Definitions
  • Recommendations of National Panels
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
  • Federal Reports
    • Department of Health and Human Services, Department of Agriculture. Dietary Guidelines for Americans 2005. Available at: http://www.healthierus.gov/dietaryguidelines. Accessed 20 July 2006.
    • Department of Agriculture. Mypyramid.gov. Available at http://www.mypyramid.gov. Accessed 20 July 2006.
    • National Institutes of Health/National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health; 2000. NIH Publication Number 00-4084.
    • National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults--the evidence report. Obes Res 1998;6(Suppl 2):51S-209S.
  • Research Reports
    • Alberti KG, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet 2005;366:1059-1062.
    • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
    • Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB Jr, Wagenknecht LE, Haffner SM. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 2005;112:3713-3721.
    • Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
    • Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004;109:42-46.
    • Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-252.
    • Hanley AJ, Wagenknecht LE, D'Agostino RB Jr, Zinman B, Haffner SM. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes 2003;52:2740-2747.
    • Reaven G. Syndrome X: 10 years after. Drugs 1999;58(suppl 1):19-20.
    • Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999;341:427-434.
    • World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Geneva: World Health Organization, 1999.
    • Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-468.
    • Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
• Resources on Other Websites
  • Endocannabinoid System Network (ECSN)
    • A resource for scientists and clinicians who are interested in understanding and communicating the mechanisms and functions of the endocannabinoid system, including integrating knowledge of the cellular/molecular basis with the neural and systemic effects impacting cardiovascular and metabolic risk factors and their underlying pathophysiology. The website provides a slide library, video animations, meeting highlights, bibliography and a glossary.
  • The International Chair on Cardiometabolic Risk
    • The primary objective of the International Chair on Cardiometabolic Risk is to help raise awareness of abdominal obesity and its associated metabolic complications as a new modifiable risk factor for cardiovascular disease (CVD). This Web site serves as a comprehensive, up-to-date, and easy-to-use source of information on abdominal obesity and cardiometabolic risk. It is highly interactive and features free slides, webcasts, and videos in which world-renowned experts discuss themes relevant to cardiometabolic risk.
  • Obesity Online
    • Quality scientific obesity information and educational tools for clinicians, researchers and educators with an interest in obesity and its related disorders. The site provides relevant information critical to the assessment, treatment, and management of obesity in three formats: slide library, virtual meetings, and commentaries. Visitors can register to receive notices of when new materials are posted on the website.
  • The Dyslipidemia CME E-Journal Club
    • This website offers monthly interactive CME Web sessions that provide an opportunity for physicians and other health care professionals to review and discuss a recently published peer-reviewed journal article with one of the authors of the featured article. The Network for Continuing Medical Education (NCME) is the credit provider for these activities.